![Liam Ratcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Dr. Liam Ratcliffe is an Independent Director at OnKure Therapeutics, Inc., an Independent Director at Upstream Bio, Inc., an Independent Director at Disc Medicine, Inc., a Head-Biotechnology at Access Industries LLC, a Director & Manager at Halda Therapeutics OpCo, Inc. and a Partner at Access Biotechnology (Venture Capital).
He is on the Board of Directors at OnKure Therapeutics, Inc., Draig Therapeutics Ltd., Vima Therapeutics, Inc., Upstream Bio, Inc., Recludix Pharma, Inc., Disc Medicine Opco, Inc., Disc Medicine, Inc., Arvinas Operations, Inc., Jamanda Ltd. and Halda Therapeutics OpCo, Inc. Dr. Ratcliffe was previously employed as an Independent Director by Climb Bio, Inc., an Independent Non-Executive Director by Passage Bio, Inc., an Independent Director by Aptinyx, Inc., an Independent Director by Unum Therapeutics, Inc., an Independent Director by Deciphera Pharmaceuticals, Inc., an Independent Director by Arvinas, Inc., an Independent Director by Edge Therapeutics, Inc., an Independent Director by Array BioPharma, Inc., a Managing Director by New Leaf Venture Partners LLC, a Head-Clinical Research & Development by Pfizer Inc., a Head-Experimental Medicine by Pfizer Ltd., and a Non-Executive Director by Karus Therapeutics Ltd. He also served on the board at Gemini Therapeutics, Inc., Halda Therapeutics OpCo, Inc., Rallybio IPD LLC, Rallybio LLC, Afferent Pharmaceuticals, Inc., Calchan Holdings Ltd., Calchan Ltd., Convergence Pharmaceuticals Ltd., CuraSen Therapeutics, Inc., Neuronetics, Inc. and Zafgen, Inc. He received his undergraduate degree from the University of Cape Town, an MBA from Stephen M.
Ross School of Business and a doctorate degree from the University of Cape Town.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
-.--% | 07/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
DISC MEDICINE, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DISC MEDICINE, INC. | Director/Miembro de la Junta | 01/09/2019 |
| UPSTREAM BIO, INC. | Director/Miembro de la Junta | 01/10/2021 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Director/Miembro de la Junta | 01/12/2019 |
Access Industries LLC
 Access Industries LLC Provides advancement of mobility technology | Corporate Officer/Principal | 01/04/2019 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Director/Miembro de la Junta | 01/09/2019 |
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Miembro de la Junta | - |
Halda Therapeutics OpCo, Inc.
 Halda Therapeutics OpCo, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops a mechanism and therapies for the treatment of cancers | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Halda Therapeutics OpCo, Inc.
Halda Therapeutics OpCo, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops a mechanism and therapies for the treatment of cancers | Director/Miembro de la Junta | 01/12/2025 |
| CLIMB BIO, INC. | Director/Miembro de la Junta | 11/11/2024 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 33 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Access Industries LLC
Access Industries LLC Provides advancement of mobility technology | |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Provides therapies for treatment of cancer and inflammatory diseases | Health Technology |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Calchan Holdings Ltd.
 Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain | Health Technology |
Calchan Ltd.
 Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Access Biotechnology (Venture Capital)
 Access Biotechnology (Venture Capital) Investment ManagersFinance Access Biotechnology invests in both private and public companies located in the United States. The firm targets companies operating in the field of the biopharma companies. It provides financing for later stage transactions. | Finance |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Halda Therapeutics OpCo, Inc.
Halda Therapeutics OpCo, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops a mechanism and therapies for the treatment of cancers | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
